Sacubitril/valsartan is the first agent to be approved in a new class of drugs called angiotensin receptor neprilysin inhibitor (ARNI). The medication is FDA-approved to treat patients with chronic heart failure with reduced ejection fraction (HFrEF) with NYHA class II, III, or IV.
Pharmaceutical Intermediates
Sacubitril Valsartan Api Trade Information
NHAVA SHEVA MUMBAI
Cash Advance (CA) Cash in Advance (CID)
5000 Kilograms Per Month
4 Days
If order is confirmed we will reimburse the sample cost
DRUM
All India
ALL
Product Description
Sacubitril/valsartan is the first agent to be approved in a new class of drugs called angiotensin receptor neprilysin inhibitor (ARNI). The medication is FDA-approved to treat patients with chronic heart failure with reduced ejection fraction (HFrEF) with NYHA class II, III, or IV.